ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
40 announcements
Promoter entity Nirani Holdings Private Limited acquired 1,52,201 shares of TruAlt Bioenergy Limited worth Rs. 6.69 Crore via open market, increasing stake to 2.11%.
Nirani Holdings, part of Trualt Bioenergy's promoter group, pledged 14 lakh equity shares valued at ₹58.10 Crore.
TruAlt Bioenergy Limited reported the creation of a pledge on 14,00,000 equity shares held by promoter entity Nirani Holdings Private Limited.
TruAlt Bioenergy's Board commented on a ₹0.05 Cr exchange fine for Listing Regulation non-compliance. The company appointed a Woman Independent Director and paid the penalty.
Trualt Bioenergy Limited will acquire an additional stake in its subsidiary, Leafiniti Bioenergy Private Limited, for ₹21.42 Crore to maintain its proportionate shareholding.
TruAlt Bioenergy will invest Rs. 8.27 Crore to acquire additional equity shares in its subsidiary, TruAlt Sumi Gas Private Limited, to support growth objectives.
Trualt Bioenergy Limited has appointed Dr. Sarvamangala R. Patil as a Non-Executive Independent Director. This board-level appointment adds expertise in biotechnology, sustainability, and industrial development.
TruAlt Bioenergy approved investments totaling ₹29.69 Crore in two subsidiaries, Leafiniti Bioenergy and TruAlt Sumi Gas, to support their expansion plans.
Nirani Holdings, a promoter group entity, acquired 50,000 shares of TruAlt Bioenergy for Rs. 2.12 Crore from the open market.
Promoter group entity Nirani Holdings acquired 69,575 shares of TruAlt Bioenergy for Rs. 2.94 Crore. This increases the promoter group's total shareholding by 0.08%.
Promoter group entity Nirani Holdings Private Limited acquired 98,700 equity shares of TruAlt Bioenergy Limited worth ₹4.06 Crore from the open market.
TruAlt Bioenergy held its 5th Annual General Meeting on August 31, 2026. The meeting covered adoption of financial statements and routine business appointments.
TruAlt Bioenergy faces a fine from NSE and BSE for non-compliance with board composition norms (Regulation 17(1)). The company is reviewing the notices received.
TruAlt Bioenergy received notices from NSE and BSE regarding fines for board composition non-compliance. The total penalty imposed is Rs. 9.10 Lakhs.
TruAlt Bioenergy Limited received a GST demand order of ₹6.60 Crore including tax, interest, and penalties from the Karnataka tax authorities regarding excess Input Tax Credit claims.
TruAlt Bioenergy Limited promoter group entity, Nirani Holdings Private Limited, acquired 20,000 equity shares. This open-market purchase increases the promoter group stake to 1.68%.
Promoter Nirani Holdings Private Limited acquired 24,200 equity shares of TruAlt Bioenergy Limited. This transaction increased their stake from 1.63% to 1.65%.
Nirani Holdings, part of the promoter group, acquired 57,801 equity shares of TruAlt Bioenergy for ₹2.76 Crore via an open market purchase.
Promoter group entity Nirani Holdings Pvt Ltd acquired 91,705 shares of Trualt Bioenergy for ₹4.37 Crore via open market, increasing stake by 0.11%.
Nirani Holdings Private Limited, a promoter group entity, acquired 21,600 shares of TruAlt Bioenergy Limited. The open-market transaction, valued at Rs. 1.00 Crore, increased its stake to 1.45%.
TruAlt Bioenergy Limited has submitted its Business Responsibility and Sustainability Report for the financial year 2025-26 in compliance with SEBI regulations.
Trualt Bioenergy Ltd has issued a notice for its 5th Annual General Meeting, scheduled for August 31, 2026, via video conferencing. The meeting will cover financial statement adoption and director/auditor appointments.
TruAlt Bioenergy appointed Mr. Deepak Sadhu as Secretarial Auditor for five years. The term begins April 1, 2026, and ends March 31, 2031.
TruAlt Bioenergy approved the slump sale of its Unit 5 to Onkar Agro Sugars & Energy Private Limited for ₹171 Crore.
TruAlt Bioenergy reported massive YoY growth in Q1 FY27, driven by a strategic pivot to multi-feed ethanol operations and inventory of lower-cost maize.
TruAlt Bioenergy reported strong Q1FY27 consolidated performance with Total Income of ₹641.41 Cr, up 96.4% YoY. Strategy centers on dual-feed ethanol integration and expansion into CBG and SAF verticals.
TruAlt Bioenergy reported strong Q1 FY27 growth, with Total Income doubling and PAT rising over 12x. Results were driven by a successful dual-feed ethanol platform integration.
Mr. Yagati Badarinarayana Ramakrishna has ceased to be an Independent Director of TruAlt Bioenergy Limited, effective July 28, 2026, upon completing his second consecutive term.
TruAlt Bioenergy Limited approved the appointment of a scrutinizer for its 5th Annual General Meeting during its board meeting held on July 28, 2026.
TruAlt Bioenergy Ltd reported revenue from operations of ₹626.9 Cr (+106.3% YoY) and net profit of ₹59.3 Cr (+1161.7% YoY) for Q1 FY27.